Oeverhaus Michael, Neumann Inga, Chen Ying, Eckstein Anja
Klinik für Augenheilkunde, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland.
Ophthalmologie. 2024 Jul;121(7):548-553. doi: 10.1007/s00347-024-02073-x. Epub 2024 Jun 26.
Endocrine orbitopathy (EO) is an autoimmune disease mostly associated with a disease of the thyroid gland, which leads to inflammation, adipogenesis and fibrosis. The severity of EO can vary greatly between individuals, which makes it difficult to exactly predict the natural course of the disease; however, this is important to be able to individually adapt the treatment. The aim of this study was to compare the clinical features, course, treatment and prognosis for patients with EO under 50 years old with older patients. The results of the study with a focus on motility are presented in this special issue.
The hospital records of a randomly selected sample of 1000 patients from the EO databank in Essen (GODE), which includes 4260 patients, were analyzed. The patients were divided into two groups: group 1 ≤50 years and group 2 >50 years. Only patients with complete data sets were included in the statistical analyses.
Younger patients (n = 484) presented significantly more frequently with milder EO (53% vs. 33%, p < 0.0001), whereas older patients (n = 448) more frequently suffered from moderate or severe forms (44% vs. 64%, p < 0.0001). Older patients showed more severe strabismus, motility and clinical activity scores (5.9 vs. 2.3 prism diopters, PD/310° vs. 330°, both p < 0.0001, CAS 2.1 vs. 1.7, p = 0.001). Proptosis and the occurrence of optic nerve compression showed no significant differences between the groups (3% each). Multiple logistic regression showed that the necessity for a second eye muscle surgery was most strongly associated with a previous decompression (OR = 0.12, 95 % CI 0.1-0.2, p < 0.0001), followed by orbital irradiation and age.
In summary, younger patients with EO presented with milder clinical features, such as a lower rate of restrictive motility disorders and weaker expression of signs of inflammation. Therefore, older patients needed steroids, irradiation, eyelid and eye muscle surgery more frequently; however, the risk of dysthyroid optic neuropathy and the necessity of a second eye surgery were not or only slightly associated with age.
内分泌性眼眶病(EO)是一种自身免疫性疾病,主要与甲状腺疾病相关,可导致炎症、脂肪生成和纤维化。EO的严重程度在个体之间差异很大,这使得准确预测疾病的自然病程变得困难;然而,能够根据个体情况调整治疗方案很重要。本研究的目的是比较50岁以下EO患者与老年患者的临床特征、病程、治疗和预后。本期特刊展示了这项以眼球运动为重点的研究结果。
对从埃森EO数据库(GODE)中随机抽取的1000例患者(该数据库共包含4260例患者)的医院记录进行分析。患者分为两组:第1组年龄≤50岁,第2组年龄>50岁。只有具有完整数据集的患者才纳入统计分析。
年轻患者(n = 484)出现轻度EO的频率显著更高(53%对33%,p < 0.0001),而老年患者(n = 448)更常患有中度或重度形式的EO(44%对64%,p < 0.0001)。老年患者的斜视、眼球运动和临床活动评分更严重(5.9对2.3棱镜度,PD/310°对330°,p均< 0.0001,临床活动评分2.1对1.7,p = 0.001)。两组之间眼球突出和视神经受压的发生率无显著差异(均为3%)。多因素逻辑回归显示,二次眼肌手术的必要性与既往减压手术的关联最为密切(比值比[OR]=0.12,95%置信区间[CI]0.1 - 0.2,p < 0.0001),其次是眼眶放疗和年龄。
总之,年轻的EO患者临床特征较轻,如限制性眼球运动障碍发生率较低,炎症体征表达较弱。因此,老年患者更频繁地需要使用类固醇、放疗、眼睑和眼肌手术;然而,甲状腺功能异常性视神经病变的风险以及二次眼部手术的必要性与年龄无关联或仅有轻微关联。